ELLEN SAM: Open Payments
NPI 1740379825 · AVENTURA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 52 payments from 15 companies in 2025. Trend: 2023 $717 · 2024 $545 · 2025 $1,435
Food & beverage: $1,435
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $305 |
| Regeneron Healthcare Solutions, Inc. | 6 | $184 |
| GlaxoSmithKline, LLC. | 11 | $165 |
| Genentech, Inc. | 1 | $139 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $120 |
| BioCryst US Sales Co., LLC | 3 | $82 |
| GENZYME CORPORATION | 3 | $79 |
| Ionis Pharmaceuticals, Inc. | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Optinose US, Inc. | 2 | $57 |
Products named: DUPIXENT, AIRSUPRA, Xolair, NEFFY, NUCALA, TEZSPIRE, ORLADEYO, Xhance.
Industry payments across FL — which companies pay providers there.
